<p>HIV-1 PSVs on a pSG3Δenv backbone and bearing Env from strains ADA or JR-CSF, were concentrated (20×) in PBS and incubated for 1 h at 1, 2 or 5 times their original concentration at various temperatures for 1 h prior to determination of infectivity using TZM-bl cells. (<b>A</b>) Absolute infectivity following heat treatment of HIV-1 PSVs at different virus input levels over a >10-fold range (1×10<sup>5</sup>–2×10<sup>6</sup> RLU/0.1 ml, demarcated by triangles). (<b>B</b>) Data from panel A normalized for input infectivity, indicating T<sub>90</sub> value is independent of virus input. HIV-1 PSVs used in panel A were examined for relative levels of p24 (<b>C</b>), and gp120 (<b>D</b>), using p24 or gp120 ELISA, respectively. (<b>E</b>) R...
<p>HIV-1 LAI-chimeric MCs bearing Envs of JR-CSF (top), JR-FL (middle) and ADA (bottom) were treated...
<p>(<b>A</b>) Half-life (t<sub>1/2</sub>) of infectivity decay at 37°C and (<b>B</b>) thermostabilit...
Neutralization of human immunodeficiency virus type 1 by adding antibody after the virus has attache...
1<p>T<sub>90</sub>, the temperature at which HIV-1 infectivity decreases by 90% in 1 h, and the stan...
1<p>Infectivities were determined in TZM-bl cells and the resulting relative light units (RLUs) were...
<p>A: Infection of Jurkat cells with single-cycle HIV. One representative experiment is shown. Cells...
<p>(<b>A</b>) Bar graph indicating the various T<sub>90</sub> values with that of the thermostable H...
<p>HIV-1 mutant K574A was tested for resistance to heat in either the LAI (<b>A</b>) or JR-FL (<b>B<...
<p>(<b>A</b>) BN-PAGE analysis of the thermostability of wildtype HIV-1<sub>LAI-JR-FL</sub> and SOS-...
<p>A: Experimental Outline. Jurkat or primary CD4+ T cells were infected with HIV-1 NL4-3 for 2 hour...
<p>(A,B) Binding of the indicated ligands to the HIV-1<sub>JR-FL</sub> Env(-)Δ808-NDs that had been ...
The HIV-1 envelope glycoprotein (Env) spike is challenging to study at the molecular level, due in p...
The HIV-1 envelope glycoprotein (Env) spike is challenging to study at the molecular level, due in p...
International audienceHIV-infected individuals may experience fever episodes. Fever is an elevation ...
<div><p>HIV-infected individuals may experience fever episodes. Fever is an elevation of the body te...
<p>HIV-1 LAI-chimeric MCs bearing Envs of JR-CSF (top), JR-FL (middle) and ADA (bottom) were treated...
<p>(<b>A</b>) Half-life (t<sub>1/2</sub>) of infectivity decay at 37°C and (<b>B</b>) thermostabilit...
Neutralization of human immunodeficiency virus type 1 by adding antibody after the virus has attache...
1<p>T<sub>90</sub>, the temperature at which HIV-1 infectivity decreases by 90% in 1 h, and the stan...
1<p>Infectivities were determined in TZM-bl cells and the resulting relative light units (RLUs) were...
<p>A: Infection of Jurkat cells with single-cycle HIV. One representative experiment is shown. Cells...
<p>(<b>A</b>) Bar graph indicating the various T<sub>90</sub> values with that of the thermostable H...
<p>HIV-1 mutant K574A was tested for resistance to heat in either the LAI (<b>A</b>) or JR-FL (<b>B<...
<p>(<b>A</b>) BN-PAGE analysis of the thermostability of wildtype HIV-1<sub>LAI-JR-FL</sub> and SOS-...
<p>A: Experimental Outline. Jurkat or primary CD4+ T cells were infected with HIV-1 NL4-3 for 2 hour...
<p>(A,B) Binding of the indicated ligands to the HIV-1<sub>JR-FL</sub> Env(-)Δ808-NDs that had been ...
The HIV-1 envelope glycoprotein (Env) spike is challenging to study at the molecular level, due in p...
The HIV-1 envelope glycoprotein (Env) spike is challenging to study at the molecular level, due in p...
International audienceHIV-infected individuals may experience fever episodes. Fever is an elevation ...
<div><p>HIV-infected individuals may experience fever episodes. Fever is an elevation of the body te...
<p>HIV-1 LAI-chimeric MCs bearing Envs of JR-CSF (top), JR-FL (middle) and ADA (bottom) were treated...
<p>(<b>A</b>) Half-life (t<sub>1/2</sub>) of infectivity decay at 37°C and (<b>B</b>) thermostabilit...
Neutralization of human immunodeficiency virus type 1 by adding antibody after the virus has attache...